Stewart Tepper

Feb 21, 2025 | neurologylive.com | Stewart Tepper |Isabella Ciccone

WATCH TIME: 6 minutes"What we're really after clinically is ‘one and done.’ We want to treat and have [the patient] pain-free in 2 hours, without significant [adverse] effects most of the time, and without a recurrence of the headache.”Combination therapies in migraine management involve using 2 or more treatments, either acute or preventive, together to address different aspects of the migraine process.

Feb 5, 2025 | neurologylive.com | Stewart Tepper |Isabella Ciccone

WATCH TIME: 4 minutes“The hope is that as we educate practitioners, the understanding of why combining an [nonsteroidal anti-inflammatory drug] with a triptan should provide additional benefit in the acute treatment of migraine for patients will become more and more clear, and that is my hope for the future."Migraine is a debilitating neurological disorder marked by recurrent episodes of pulsating head pain, often accompanied by nausea and sensitivity to light and sound.

Oct 2, 2023 | neurologylive.com | Stewart Tepper

WATCH TIME: 5 minutes“This is very exciting because we do have patients that don't seem to respond to the anti-CGRP drugs and [PACAP] represents a new target. The patients that were involved in this study had between 2 and 4 preventive medications that failed.

Jun 14, 2023 | headachejournal.onlinelibrary.wiley.com | Stewart Tepper |Richard Lipton |Albert Einstein College |Stephen D Silberstein

CONFLICT OF INTEREST STATEMENT Stewart J.

May 15, 2023 | neurologylive.com | Stewart Tepper

WATCH TIME: 3 minutesOver 1 billion patients worldwide are affected by migraines, causing significant disability to patients and increased socioeconomic burden.1 In the migraine community, preventive treatments are underutilized even though they are part of the key to managing the condition. Thus, there is an unmet need for nonpharmacological interventions for migraine prevention that are both well-tolerated and effective.